VRBPAC Meeting on COVID-19 Vaccine Strain Composition Decisions
The VRBPAC will meet in open session on 28 June 2022 to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified. FDA intends to make
The VRBPAC will meet in open session on 28 June 2022 to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified. FDA intends to make
Discover the latest achievements in the fight against the pneumococcus at the ISPPD-12 International Symposium on Pneumococci and Pneumococcal Diseases 19-23 June 2022 in Toronto. This meeting was originally scheduled
The VRBPAC will meet in open session to discuss amending the EUA of the Moderna COVID-19 mRNA vaccine to include the administration of the primary series to infants and children